Riboxx GmbH
Research - Radebeul, Saxony, Germany
Riboxx GmbH Employees
Riboxx GmbH Details
Riboxx develops RNA molecules with unique properties. These molecules are dedicated to the following applications: - Vaccines: Development of dsRNA molecules that activate innate immunity. These are used as adjuvants for therapeutic vaccines (e.g. against cancer and infections) and prophylactic vaccines (e.g. against infections). - Oncology & Infections: Development of Toll-like receptor 3 (TLR3) agonists. TLR3 agonists are used in immunotherapy against cancer and/or infectious diseases.- Gene silencing: Development of customized and tailor-made molecular tools for gene silencing in vitro and in vivo.
Riboxx GmbH Technologies
E-commerce Platforms
Magento 2 Community
Load Balancers
Apache
Other
Mobile Friendly
Analytics and Tracking
Google Analytics